Arena Pharmaceuticals, Inc. (ARNA)

[SpeculativeHoldings]

July 15 marks an important day for VVUS and it's candidate Qnexa...

What is the FDA thinking? - One may never know, however; there are a few ways to spin it with ARNA.

ARNA trades upwards in July. This is a given. Why? Investors will be using that July 15th FDA panel as a potential catalyst.

If things don't pan out for VVUS on July 15th, then this will be HUGE for ARNA, for it now will be directly in the spotlight for approval.

Even if July 15th presents VVUS investors with good news, ARNA will STILL potentially trade forward on the idea that the FDA has opened it's doors to the metabolic drug category. What have we got in the obesity category? Just about NOTHING (Pancreatic lipase inhibiting Orlistat is DISAPPOINTING, doesn't work well, and is already out of the Rx game, for it's available OTC as Alli on store shelves nationwide- let's not go there)!!! ARNA's Lorcaserin is SAFER and very different than Qnexa. It will have it's own niche in the market place. It's the only drug that can be used as a first line treatment.

I expect approval in October, so i'm LONG LONG in ARNA... BUT, there's no reason why ARNA flippers can't make money in the short term. We'll see a higher PPS in weeks to come.

I welcome you to churn it. See you at the top.